Bee Vectoring Technologies International Inc. (BEVVF)
- Previous Close
0.0000 - Open
0.0075 - Bid 0.0075 x --
- Ask 0.0090 x --
- Day's Range
0.0075 - 0.0075 - 52 Week Range
0.0020 - 0.1560 - Volume
3,000 - Avg. Volume
12,888 - Market Cap (intraday)
1.627M - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Bee Vectoring Technologies International Inc. focuses on the control of pests, and enhancement of crops and ornamentals through the biological controls in a variety of application processes in the United States. The company's solutions comprise the Hive & Bees, an inoculum dispenser system; Vectorpak, a removable, easy-to-use tray that contain Vectorite, a specially formulated patented powder made from various natural materials; active ingredients, such as BVT-CR7, an organic strain of a natural occurring endophytic fungus; and pollen distribution systems. Its patented and patent pending technology utilizes bees as natural delivery mechanisms for a variety of powdered mixtures comprising organic compounds, used products which inhibit, and eliminate common crop diseases. The company also provides natural pest and disease management solutions for various crops, such as strawberries, sunflowers, apples, tomatoes, canola crops, blueberries, and other crops. Bee Vectoring Technologies International Inc. is headquartered in Mississauga, Canada.
www.beevt.com--
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: BEVVF
View MorePerformance Overview: BEVVF
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BEVVF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BEVVF
View MoreValuation Measures
Market Cap
1.52M
Enterprise Value
1.95M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
14.61
Price/Book (mrq)
3.97
Enterprise Value/Revenue
23.65
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-35.15%
Return on Equity (ttm)
-286.23%
Revenue (ttm)
115.21k
Net Income Avi to Common (ttm)
-4.63M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
26.42k
Total Debt/Equity (mrq)
116.14%
Levered Free Cash Flow (ttm)
223.29k